Prism has facilitated the acquisition of medical device design consultancy Springboard Pro Ltd by Sanner GmbH to enhance Sanner's development capabilities in the healthcare sector.
Information on the Target
Springboard Pro Ltd, founded in 2013 and based in Cambridge, specializes in the design and development of medical technology devices. The company excels in guiding projects from initial concept through to manufacturing specifically tailored for regulated markets, including medical, drug delivery, and biotechnology sectors. Springboard's team comprises adept engineers and scientists with expertise in engineering, physics, electronics, software, design, and materials science, all unified by a commitment to tackle complex technical challenges and deliver successful products that benefit individuals globally.
Industry Overview in the Target’s Specific Country
The medical technology industry in the UK is rapidly evolving, characterized by significant investments in innovation and development. With a strong emphasis on research and development, the UK is a hotbed for biotech firms and medical device manufacturers, fostering an environment conducive to technological advancements. This sector contributes substantially to the national economy and is regarded as one of the most promising fields for growth due to the ongoing necessitation of healthcare solutions.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Regulatory standards in the UK for medical devices are strict, ensuring that safety and efficacy are paramount in product development. Organizations operati
Similar Deals
Teleflex Incorporated → Vaskuläre Intervention (VI) business unit of BIOTRONIK
2025
Sanner GmbH
invested in
Springboard Pro Ltd
in 2024
in a Merger deal